Weijie Ye

1.3k citations
16 papers · 946 indexed · 1 hit paper · h-index 10
Topics
Immune cells in cancer (7 papers)Glioma Diagnosis and Treatment (4 papers)Ferroptosis and cancer prognosis (3 papers)

In The Last Decade

Weijie Ye

16 papers receiving 941 citations

Hit Papers

Glioma targeted therapy: insight into future of molecular...20222026202320242022100200300400

Peers

Weijie Ye
Comparison fields: 5 of 88
  • Molecular Biology 372
  • Immunology 257
  • Genetics 231
  • Cancer Research 191
  • Pulmonary and Respiratory Medicine 184
Replace Donata Simińska with:
Donata Simińska Poland
Wenjie Ma China
Ling Cen United States
Tianrun Liu China
Byung‐Gyu Kim United States
Jinbiao Chen Australia
João Incio United States
Reginald Brys Belgium
Kwang‐Yu Chang Taiwan
Xiaodong Zhu China
Weijie Ye relative to Donata Simińska Poland Donata Simińska's profile →
Citations per field
00.5×6.9×
Donata Simińska · 1×
Citations per year

Countries citing papers authored by Weijie Ye

Since Specialization
Citations

This map shows the geographic impact of Weijie Ye's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Weijie Ye with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Weijie Ye more than expected).

Fields of papers citing papers by Weijie Ye

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Weijie Ye. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Weijie Ye. The network helps show where Weijie Ye may publish in the future.

Co-authorship network of co-authors of Weijie Ye

This figure shows the co-authorship network connecting the top 25 collaborators of Weijie Ye. A scholar is included among the top collaborators of Weijie Ye based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Weijie Ye. Weijie Ye is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

16 of 16 papers shown
#WorkIndexed citations
1 2
2 1
3 13
4 9
5 44
6
Glioma targeted therapy: insight into future of molecular approachesbreakdown →
458
7 2
8 22
9 9
10 25
11 279
12 3
13 21
14 24
15 16
16 18

About Weijie Ye

Weijie Ye is a scholar working on Immunology, Genetics and Psychiatry and Mental health, having authored 16 papers that have together received 946 indexed citations. Recurring topics across this work include Immune cells in cancer (7 papers), Glioma Diagnosis and Treatment (4 papers) and Ferroptosis and cancer prognosis (3 papers). The work is most often cited by research in Genetics (231 citations), Cancer Research (191 citations) and Immunology (257 citations). Weijie Ye has collaborated with scholars based in China, United Kingdom and United States. Frequent co-authors include Quan Cheng, Zeyu Wang, Hao Zhang, Zhixiong Liu, Ziyu Dai, Liyang Zhang, Nan Zhang, Wantao Wu, Xun Zhang and Keyang Yang. Their work appears in journals such as Nature Communications, ACS Applied Materials & Interfaces and Frontiers in Immunology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026